June 30, 2025

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Growth with a 75% Revenue Surge Amidst Market Volatility

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, attracting significant attention with its impressive revenue growth of 75.40%. This Chicago-based company, specializing in advanced healthcare..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Uncovering a 27.40% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $15.72 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and a Promising 27.6% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS), a key player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to innovative cancer screening and..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 28.68% Potential Upside for Investors

For individual investors seeking opportunities in the healthcare sector, Merck & Company, Inc. (NYSE: MRK) presents a compelling case with a potential upside of 28.68%. With a market capitalization of..

Zoetis Inc. (ZTS) Stock Analysis: Strong Buy Ratings and 24.89% Potential Upside Drive Investor Interest

Zoetis Inc. (NYSE: ZTS), a leader in the healthcare sector, continues to capture investor attention with its robust market presence and potential for significant upside. With a market capitalization of..

ResMed Inc. (RMD) Stock Analysis: Navigating Growth in Healthcare with a 25.81% ROE

ResMed Inc. (RMD), a titan in the healthcare sector, is making waves in the medical instruments and supplies industry. With a solid market capitalization of $37.41 billion, ResMed stands as..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 27.49% Potential Upside in the Medical Instruments Sector

Investors are turning their gaze towards Becton, Dickinson and Company (NYSE: BDX), a heavyweight in the healthcare sector specializing in medical instruments and supplies. With a market capitalization of $48.97..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, commands a significant presence in the pharmaceutical and medical technology industries. With a market capitalization of $366.71 billion, this..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: A 9.7% Upside Potential Amidst Steady Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, stands out in the medical devices industry with its robust market presence and innovative product offerings. With..

Incyte Corporation (INCY): Investor Outlook on Promising Biotech Growth with 9.91% Potential Upside

Incyte Corporation (NASDAQ: INCY) stands as a compelling player in the biotechnology sector, with its focus on the discovery, development, and commercialization of groundbreaking therapeutics. Headquartered in Wilmington, Delaware, the..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 17.54% Potential Upside with Analyst Ratings in Focus

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, operates as a medical device company with a robust portfolio of orthopedic reconstructive products. With a market..

BioNTech SE (BNTX) Stock Analysis: Navigating a 28% Potential Upside with Strategic Investments in Immunotherapy

BioNTech SE (NASDAQ: BNTX), the German biotechnology powerhouse, has been a focal point for investors aiming to capitalize on advancements in cancer and infectious disease therapies. As of now, the..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 27% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a stalwart in the healthcare diagnostics and research industry, presents a compelling opportunity for investors seeking exposure to the life sciences sector. With a market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 21% Potential Upside for Investors

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, is making waves in the investment community with its robust growth metrics and potential upside, currently pegged..

Cencora, Inc. (COR) Stock Analysis: Exploring a Robust 7.37% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, has been making waves in the medical distribution industry. With a solid market cap of $58.03 billion, the company..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 20.48% Upside Potential for Investors

Alcon Inc. (NYSE: ALC), a leader in the global eye care industry, is making waves in the healthcare sector with its robust portfolio of innovative products and promising growth potential...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 17% Potential Upside Beckons Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player within the healthcare sector, specifically focusing on health information services. With a market capitalization of $34.06 billion, this U.S.-based..

Illumina, Inc. (ILMN) Stock Analysis: Unveiling a 14.87% Potential Upside Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector, is renowned for its cutting-edge genomic and genetic sequencing solutions. Headquartered in San Diego, California, Illumina plays a pivotal role..

Insulet Corporation (PODD) Stock Analysis: A Look at its Robust Revenue Growth and Analyst Optimism

Insulet Corporation (NASDAQ: PODD), a pioneer in the medical devices sector, is making waves with its innovative insulin delivery systems. As a leader in healthcare technology, Insulet has captured investor..

argenx SE (ARGX) Stock Analysis: Unveiling a 38.75% Potential Upside Fueled by Breakthrough Biotech Innovations

argenx SE (NASDAQ: ARGX), a pioneering name in the biotechnology sector, is capturing the attention of investors with its robust growth trajectory and promising drug pipeline. Based in the Netherlands,..

Search

Funds

June 30, 2025

Search

Funds

June 30, 2025

FTSE 100

Funds